Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 20, 2018

SELL
$135.59 - $157.16 $357,686 - $414,588
-2,638 Closed
0 $0
Q4 2017

Jan 26, 2018

SELL
$131.06 - $150.39 $1.89 Million - $2.17 Million
-14,412 Reduced 84.53%
2,638 $355,000
Q3 2017

Oct 24, 2017

BUY
$142.62 - $155.6 $2.43 Million - $2.65 Million
17,050
17,050 $2.49 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.87B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Consolidated Investment Group LLC Portfolio

Follow Consolidated Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Investment Group LLC with notifications on news.